- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Gestational diabetes increases risk of heart disease in baby ,Study finds
Diabetes during pregnancy known as gestational diabetes may increase the risk of heart disease and blood vessel dysfunction in the offspring through alteration of a smooth muscle protein required for the formation of blood vessel network, according to a new study.
Researchers of the study, published in the American Journal of Physiology-Cell Physiology, further comments that understanding function of the protein may improve early disease detection in children.
Read Also: New study reveals adverse impact of both type 2 and type 1 diabetes on pregnancy outcomes
The investigators hypothesized that increased TAGLN expression in GDM-exposed fetal ECFCs decreases network formation by impairing cytoskeletal rearrangement resulting in reduced cell migration.
For the study, cord blood samples taken at the time of birth from women with GDM were compared to a control group without pregnancy complications. Cord blood ECFCs do not typically contain high levels of transgelin. However, the samples taken from the umbilical cord blood of the group showed higher protein levels and increased dysfunction of the blood vessels during formation. Decreasing transgelin in the diabetes-exposed cells "significantly improved initial [blood vessel] network formation, ongoing network stabilization, and cell migration," wrote the researcher's team.
"The data suggest that increased TAGLN likely contributes to the vasculogenic dysfunction observed in GDM-exposed ECFCs, as it impairs ECFC migration, cell alignment, and network formation. Identifying the molecular mechanisms underlying fetal ECFC dysfunction following GDM exposure is key to ascertain mechanistically the basis for cardiovascular disease predisposition later in life," concluded the authors.
For further information log on to http://dx.doi.org/10.1152/ajpcell.00137.2018
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd